Cycle Pharmaceuticals has received approval from the FDA of its Abbreviated New Drug Application (“ANDA”) for Ketorolac Tromethamine Tablets 10mg. Ketorolac Tromethamine Tablets, a nonsteroidal anti-inflammatory drug (“NSAID”), are indicated for the short-term (up to five days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment…